Is there Progress? An Overview of Select Biomarker Candidates for Major Depressive Disorder
Major Depressive Disorder (MDD) contributes to a significant worldwide disease burden, expected to be second only to heart disease by 2050. However, accurate diagnosis has been a historical weakness in clinical psychiatry. As a result, there is a demand for diagnostic modalities with greater objec...
Main Authors: | Juan Joseph Young, Tim eSilber, Davide eBruno, Isaac Robert Galatzer-Levy, Nunzio ePomara, Charles Raymond Marmar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-04-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fpsyt.2016.00072/full |
Similar Items
-
Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study
by: Kenji Hashimoto, et al.
Published: (2017-06-01) -
Diagnostic value of methylated human telomerase reverse transcriptase (hTERT) in human cancers: a meta-analysis
by: Wei eGao, et al.
Published: (2015-12-01) -
Hippocampus and basal forebrain volumes modulate effects of anticholinergic treatment on delayed recall in healthy older adults
by: Stefan J. Teipel, et al.
Published: (2015-06-01) -
Development and Characterization of Near-Isogenic Lines Revealing Candidate Genes for a Major 7AL QTL Responsible for Heat Tolerance in Wheat
by: Lu Lu, et al.
Published: (2020-08-01) -
Loop-mediated isothermal amplification (LAMP) test for diagnosis of uncomplicated malaria in endemic areas: a meta-analysis of diagnostic test accuracy
by: Denesh Selvarajah, et al.
Published: (2020-06-01)